VE

Vidyaman Eknath Kankal

Active Director Managing Director DIN 11561858
DIN 11561858 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Vidyaman Eknath Kankal

Data last updated:

Vidyaman Eknath Kankal is a Managing Director at Rasamrut Ayurved Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11561858
Primary Designation Managing Director
Industry Pharma
First Appointment 18 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director18 Feb 20262026Active

Board colleagues of Vidyaman Eknath Kankal

Directorship timeline

Open interactive timeline →
Rasamrut Ayurved Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vidyaman Eknath Kankal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vidyaman Eknath Kankal

Vidyaman Eknath Kankal currently holds 1 directorship: Rasamrut Ayurved Pharmaceuticals Private Limited (Managing Director, since 18 Feb 2026).

Vidyaman Eknath Kankal was first appointed on 18 Feb 2026 as Managing Director at Rasamrut Ayurved Pharmaceuticals Private Limited.

The current boards of Vidyaman Eknath Kankal's companies include Ganesh Ramdas Gawande (Rasamrut Ayurved Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available